Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07308847 · ClinicalTrials.gov registry record · NA
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
A NA study of Paroxysmal AF, sponsored by Medtronic Cardiac Ablation Solutions.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 9
- Study locations
NCT07308847 is a NA study of Paroxysmal AF that is actively recruiting participants, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 300 participants. The trial reports 9 study locations across 7 states.
The verdict
NCT07308847, a NA study of Paroxysmal AF, is actively recruiting participants, sponsored by Medtronic Cardiac Ablation Solutions.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 9
- Study locations
Study Summary
The study is a prospective, single-arm, pre-market clinical study and will enroll up to 300 subjects at up to 26 sites in the United States (US) for analysis of primary objectives. No single site may contribute more than 15% of the enrollments.
Conditions Studied
Interventions
- DEVICE Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System
Study Locations (9)
Massachusetts
- Massachusetts General Hospital - Boston
- Southcoast Health System - Fall River
New York
- Icahn School of Medicine at Mount Sinai - New York
- Northwell Health Lenox Hill Hospital - New York
Arkansas
- Arrhythmia Research Group - Jonesboro
Illinois
- Northwestern University - Chicago
North Carolina
- Atrium Health Wake Forest Baptist Medical Center - Winston-Salem
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2027-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07308847
The ClinicalTrials.gov registry entry for NCT07308847 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal AF appearing as the primary indexed condition, and to 1 intervention - of which Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System is the first listed.
NCT07308847 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Massachusetts, New York, Arkansas.
Frequently Asked Questions
What is clinical trial NCT07308847 about?
NCT07308847 is a clinical study titled "Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)". The study is a prospective, single-arm, pre-market clinical study and will enroll up to 300 subjects at up to 26 sites in the United States (US) for analysis of primary objectives. No single site may contribute more than 15% of the enrollments.
What is the current status of trial NCT07308847?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-01-15. Estimated completion is 2027-11-22.
What conditions does trial NCT07308847 study?
This clinical trial studies the following conditions: Paroxysmal AF.
What interventions are being tested in trial NCT07308847?
The interventions under investigation include: Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System (DEVICE).
Who is sponsoring clinical trial NCT07308847?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07308847 being conducted?
This trial has 9 study locations across Arkansas, Illinois, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal AF
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.